Immunization with a ZmpB-based protein vaccine could protect against pneumococcal diseases in mice

Infection and Immunity

Volumn 79, Issue 2, 2011, Pages 867-878

  Gong, Yi ^a   Xu, Wenchun ^a   Cui, Yali ^a   Zhang, Xuemei ^a   Yao, Run ^a   Li, Dairong ^a   Wang, Hong ^a   He, Yujuan ^a   Cao, Ju ^a   Yin, Yibing ^a  

^a CHONGQING MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTISERUM; BACTERIAL VACCINE; CHOLERA TOXIN; POLYCLONAL ANTIBODY; RECOMBINANT HEAT SHOCK PROTEIN 40; RECOMBINANT PNEUMOLYSIN; RECOMBINANT PROTEIN; RECOMBINANT SUMO PROTEIN; RECOMBINANT ZINC METALLOPROTEASE B VACCINE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY TITER; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL STRAIN; CELL ADHESION; CELL SURFACE; COLONY FORMING UNIT; CONTROLLED STUDY; DRUG EFFICACY; ENZYME LINKED IMMUNOSORBENT ASSAY; ESCHERICHIA COLI; FEMALE; FLOW CYTOMETRY; IMMUNITY; MOLECULAR CLONING; MOUSE; NONHUMAN; PASSIVE IMMUNIZATION; PNEUMOCOCCAL INFECTION; PRIORITY JOURNAL; STREPTOCOCCUS PNEUMONIA; STREPTOCOCCUS PNEUMONIAE; SURVIVAL TIME; TREATMENT RESPONSE; WESTERN BLOTTING;

ADJUVANTS, IMMUNOLOGIC; ADMINISTRATION, MUCOSAL; ANIMALS; BACTERIAL PROTEINS; BACTERIAL VACCINES; METALLOENDOPEPTIDASES; MICE; MICE, INBRED BALB C; PNEUMOCOCCAL INFECTIONS; RECOMBINANT PROTEINS; STREPTOLYSINS;

EID: 79251523147     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.00717-10     Document Type: Article

References (46)

1. Arvå, E., and B. Andersson. 1999. Induction of phagocyte- stimulating and Th1-promoting cytokines by in vitro stimulation of human peripheral blood mononuclear cells with Streptococcus pneumoniae. Scand. J. Immunol. 49:417-423.
2. Audouy, S. A., et al. 2007. Development of lactococcal GEM-based pneumococcal vaccines. Vaccine 25:2497-2506.
3. Beghetto, E., et al. 2006. Discovery of novel Streptococcus pneumoniae antigens by screening a whole-genome lambda λ-display library. FEMS. Microbiol. Lett. 262:14-21.
4. Blue, C. E., et al. 2003. ZmpB, a novel virulence factor of Streptococcus pneumoniae that induces tumor necrosis factor alpha production in the respiratory tract. Infect. Immun. 71:4925-4935.
5. Bogaert, D., et al. 2004. Colonisation by Streptococcus pneumoniae and Staphylococcus aureus in healthy children. Lancet 363:1871-1872.
6. Bogaert, D., R. De Groot, and P. W. Hermans. 2004. Streptococcus pneumoniae colonisation: the key to pneumococcal disease. Lancet Infect. Dis. 4:144-154.
7. Briles, D. E., et al. 2003. Immunizations with pneumococcal surface protein A and pneumolysin are protective against pneumonia in a murine model of pulmonary infection with Streptococcus pneumoniae. J. Infect. Dis. 188:339-348.
8. Brueggemann, A. B., R. Pai, D. W. Crook, and B. Beall. 2007. Vaccine escape recombinants emerge after pneumococcal vaccination in the United States. PLoS. Pathog. 3:e168.
9. Butt, T. R., S. C. Edavettal, J. P. Hall, and M. R. Mattern. 2005. SUMO fusion technology for difficult-to-express proteins. Protein Expr. Purif. 43:1-9.
10. Camilli, R., et al. 2006. Zinc metalloproteinase genes in clinical isolates of Streptococcus pneumoniae: association of the full array with a clonal cluster comprising serotypes 8 and 11A. Microbiology 152:313-321. (Pubitemid 43210662)
11. Cao, J., et al. 2007. Enhanced protection against pneumococcal infection elicited by immunization with the combination of PspA, PspC, and ClpP. Vaccine 25:4996-5005.
12. Chen, Y., A. Hayashida, A. E. Bennett, S. K. Hollingshead, and P. W. Park. 2007. Streptococcus pneumoniae sheds syndecan-1 ectodomains through ZmpC, a metalloproteinase virulence factor. J. Biol. Chem. 282:159-167.
13. Chiavolini, D., et al. 2003. The three extra-cellular zinc metalloproteinases of Streptococcus pneumoniae have a different impact on virulence in mice. BMC. Microbiol. 3:14.
14. Daniels, C. C., et al. 2010. The proline-rich region of pneumococcal surface proteins A and C contains surface-accessible epitopes common to all pneumococci and elicits antibody-mediated protection against sepsis. Infect. Immun. 78:2163-2172.
15. Gianfaldoni, C., et al. 2007. Streptococcus pneumoniae pilus subunits protect mice against lethal challenge. Infect. Immun. 75:1059-1062.
16. Gianfaldoni, C., et al. 2009. Sortase A confers protection against Streptococcus pneumoniae in mice. Infect. Immun. 77:2957-2961.
17. Giefing, C., et al. 2008. Discovery of a novel class of highly conserved vaccine antigens using genomic scale antigenic fingerprinting of pneumococcus with human antibodies. J. Exp. Med. 205:117-131.
18. Gor, D. O., X. Ding, D. E. Briles, M. R. Jacobs, and N. S. Greenspan. 2005. Relationship between surface accessibility for PpmA, PsaA, and PspA and antibody-mediated immunity to systemic infection by Streptococcus pneumoniae. Infect. Immun. 73:1304-1312.
19. Greene, C. M., et al. 2006. Preventability of invasive pneumococcal disease and assessment of current polysaccharide vaccine recommendations for adults: United States, 2001-2003. Clin. Infect. Dis. 43:141-150.
20. Hsieh, Y. C., et al. 2008. Establishment of a young mouse model and identification of an allelic variation of zmpB in complicated pneumonia caused by Streptococcus pneumoniae. Crit. Care. Med. 36:1248-1255.
21. Jahn-Schmid, B., et al. 1996. Toward selective elicitation of TH1-controlled vaccination responses: vaccine applications of bacterial surface layer proteins. J. Biotechnol. 44:225-231. (Pubitemid 126353118)
22. Kadioglu, A., J. N. Weiser, J. C. Paton, and P. W. Andrew. 2008. The role of Streptococcus pneumoniae virulence factors in host respiratory colonization and disease. Nat. Rev. Microbiol. 6:288-301.
23. Khan, A. Q., Q. Chen, Z. Q. Wu, J. C. Paton, and C. M. Snapper. 2005. Both innate immunity and type 1 humoral immunity to Streptococcus pneumoniae are mediated by MyD88 but differ in their relative levels of dependence on toll-like receptor 2. Infect. Immun. 73:298-307.
24. Khan, M. N., et al. 2006. Immunogenicity and protective efficacy of DnaJ (hsp40) of Streptococcus pneumoniae against lethal infection in mice. Vaccine 24:6225-6231.
25. Levine, O. S., et al. 2006. Pneumococcal vaccination in developing countries. Lancet 367:1880-1882.
26. Lu, Y. J., et al. 2008. Interleukin-17A mediates acquired immunity to pneumococcal colonization. PLoS. Pathog. 4:e1000159.
27. Lu, Y. J., S. Forte, C. M. Thompson, P. W. Anderson, and R. Malley. 2009. Protection against pneumococcal colonization and fatal pneumonia by a trivalent conjugate of a fusion protein with the cell wall polysaccharide. Infect. Immun. 77:2076-2083.
28. Mizrachi Nebenzahl, Y., et al. 2007. Streptococcus pneumoniae surface-exposed glutamyl tRNA synthetase, a putative adhesin, is able to induce a partially protective immune response in mice. J. Infect. Dis. 196:945-953.
29. Novak, R., et al. 2000. Extracellular targeting of choline-binding proteins in Streptococcus pneumoniae by a zinc metalloprotease. Mol. Microbiol. 36:366-376.
30. Oggioni, M. R., et al. 2003. Pneumococcal zinc metalloproteinase ZmpC cleaves human matrix metalloproteinase 9 and is a virulence factor in experimental pneumonia. Mol. Microbiol. 49:795-805.
31. Ogunniyi, A. D., M. Grabowicz, D. E. Briles, J. Cook, and J. C. Paton. 2007. Development of a vaccine against invasive pneumococcal disease based on combinations of virulence proteins of Streptococcus pneumoniae. Infect. Immun. 75:350-357.
32. Reinert, R. R. 2009. The antimicrobial resistance profile of Streptococcus pneumoniae. Clin. Microbiol. Infect. 15(Suppl. 3):7-11.
33. Reinert, R. R., P. Paradiso, and B. Fritzell. 2010. Advances in pneumococcal vaccines: the 13-valent pneumococcal conjugate vaccine received market authorization in Europe. Expert Rev. Vaccines 9:229-236.
34. Romanello, V., et al. 2006. Cloning, expression, purification, and characterization of Streptococcus pneumoniae IgA1 protease. Protein Expr. Purif. 45:142-149.
35. Saraiva, M., and A. O'Garra. 2010. The regulation of IL-10 production by immune cells. Nat. Rev. Immunol. 10:170-181.
36. Scott, J. A. 2007. The preventable burden of pneumococcal disease in the developing world. Vaccine 25:2398-2405.
37. Senior, B. W., and J. M. Woof. 2006. Sites in the CH3 domain of human IgA1 that influence sensitivity to bacterial IgA1 proteases. J. Immunol. 177:3913-3919.
38. Sette, A., et al. 2009. Definition of epitopes and antigens recognized by vaccinia specific immune responses: their conservation in variola virus sequences, and use as a model system to study complex pathogens. Vaccine 27(Suppl. 6):G21-G26.
39. Spratt, B. G., and B. M. Greenwood. 2000. Prevention of pneumococcal disease by vaccination: does serotype replacement matter? Lancet 356:1210-1211.
40. Swiatlo, E., and D. Ware. 2003. Novel vaccine strategies with protein antigens of Streptococcus pneumoniae. FEMS. Immunol. Med. Microbiol. 38:1-7.
41. van der Poll, T., and S. M. Opal. 2009. Pathogenesis, treatment, and prevention of pneumococcal pneumonia. Lancet 374:1543-1556.
42. Weinstein, M. P., K. P. Klugman, and R. N. Jones. 2009. Rationale for revised penicillin susceptibility breakpoints versus Streptococcus pneumoniae: coping with antimicrobial susceptibility in an era of resistance. Clin. Infect. Dis. 48:1596-1600.
43. Wu, H. Y., et al. 1997. Establishment of a Streptococcus pneumoniae nasopharyngeal colonization model in adult mice. Microb. Pathog. 23:127-137.
44. Wu, H. Y., M. H. Nahm, Y. Guo, M. W. Russell, and D. E. Briles. 1997. Intranasal immunization of mice with PspA (pneumococcal surface protein A) can prevent intranasal carriage, pulmonary infection, and sepsis with Streptococcus pneumoniae. J. Infect. Dis. 175:839-846.
45. Wu, K., et al. 2010. Immunization with a combination of three pneumococcal proteins confers additive and broad protection against Streptococcus pneumoniae infections in mice. Infect. Immun. 78:1276-1283.
46. Xin W., Y. Li, H. Mo, K. L. Roland, and R. Curtiss III. 2009. PspA family fusion proteins delivered by attenuated Salmonella enterica serovar Typhimurium extend and enhance protection against Streptococcus pneumoniae. Infect. Immun. 77:4518-4528.